Structural requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds.
D000470:Alkaloids / Q000138:chemical synthesis* / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D007546:Isoquinolines / Q000138:chemical synthesis* / Q000627:therapeutic use; D051381:Rats; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000470:Alkaloids; D000970:Antineoplastic Agents; D001593:Benzyl Compounds; D007546:Isoquinolines